Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study to Assess the Efficacy, Safety, and Tolerability of Vixarelimab in Reducing Pruritus in Prurigo Nodularis

ClinicalTrials.gov ID: NCT03816891

Public ClinicalTrials.gov record NCT03816891. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 5:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2a/b, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of KPL-716 in Reducing Pruritus in Subjects With Prurigo Nodularis

Study identification

NCT ID
NCT03816891
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Genentech, Inc.
Industry
Enrollment
240 participants

Conditions and interventions

Interventions

  • Vixarelimab Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 10, 2019
Primary completion
Dec 27, 2022
Completion
Aug 23, 2023
Last update posted
Jan 12, 2026

2019 – 2023

United States locations

U.S. sites
40
U.S. states
19
U.S. cities
36
Facility City State ZIP Site status
Arizona Research Center Phoenix Arizona 85053
Investigate MD, LLC Scottsdale Arizona 85255
University of Arkansas for Medical Sciences Little Rock Arkansas 72205
First OC Dermatology Fountain Valley California 92708
Center for Dermatology Clinical Research, Inc. Fremont California 94538
Dermatology Research Associates Los Angeles California 90045
Wallace Medical Group, Inc. Los Angeles California 90056
Velocity Clinical Research - North Hollywood North Hollywood California 91606
Colorado Center for Dermatology, PLLC Centennial Colorado 80111
George Washington University Medical Faculty Associates Washington D.C. District of Columbia 20037
Rybear, Inc. Fort Lauderdale Florida 33316
University of Florida, Department of Dermatology Gainesville Florida 32610
Olympian Clinical Research Largo Florida 33770
University of Miami Itch Center Miami Florida 33136
Riverchase Dermatology Pembroke Pines Florida 33028
Olympian Clinical Research St. Petersburg Florida 33709
Advanced Clinical Research Institute Tampa Florida 33607
Palm Harbor Dermatology Tampa Florida 33609
Olympian Clinical Research Tampa Florida 33614
Alliance Clinical Research of Tampa Tampa Florida 33615
Integrated Clinical Research West Palm Beach Florida 33406
Advanced Medical Research PC Sandy Springs Georgia 30328
DS Research New Albany Indiana 47150
DS Research Louisville Kentucky 40241
ALLCUTIS Research, LLC Beverly Massachusetts 01915
ActivMed Practices & Research, Inc. Methuen Massachusetts 01844
Michigan Center for Skin Care Research Clinton Township Michigan 48038
Hamzavi Dermatology Fort Gratiot Michigan 48059
Somerset Skin Centre Troy Michigan 48084
Grekin Skin Institute Warren Michigan 08088
Skin Specialists, PC Omaha Nebraska 68144
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03756
Bobby Buka MD, PC New York New York 10012
University of Rochester Dermatology at College Town Rochester New York 14620
Wright State Physicians Fairborn Ohio 45324
Paddington Testing Co., Inc. Philadelphia Pennsylvania 19103
Medical University of South Carolina, Department of Dermatology and Dermatological Surgery Charleston South Carolina 29425
Austin Institute for Clinical Research, Inc. Pflugerville Texas 78660
Progressive Clinical Research, PA San Antonio Texas 78213
Dermatology Specialists of Spokane Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 46 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03816891, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 12, 2026 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03816891 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →